BGB-8035

• Target :

  BTK|||EGFR

• Related Pathways :

  JAK/STAT signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors

• Purity :

  0.9674

• Bioactivity :

  BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

• Smiles :

  C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4

• Molecular Formula :

  C24H31N5O4

• Molecular Weight :

  453.53

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2283349-24-4